HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders.

Abstract
Because non-response (<10 IU/l anti-HBs) after revaccination for hepatitis B occurs frequently (50%), this study aimed to provide evidence for a more effective revaccination regimen by comparing four different revaccinations: (1) three revaccinations with Engerix-B(®) (n=201); (2) one revaccination with Engerix-B(®) (n=37); (3) one revaccination with HBVaxPro-40(®) (n=108); (4) one revaccination with Fendrix(®) (n=39). The level of anti-HBs antibodies was determined with the AXSYM-MEIA system (Abbott, Chicago, USA). Using linear and logistic regression, the efficacy (antibody response) after the four revaccinations was compared. Analyses were corrected for age, sex, primary titre and time lag between last revaccination and the titre measurement. The height of the primary titre independently predicted antibody response. Compared to the revaccination scheme using three Engerix-B(®) doses, revaccination with a single dose of HBVaxPro-40(®) or Fendrix(®) performed significantly better. The use of these highly potent vaccines should be considered when revaccinating hepatitis B vaccine non-responders.
AuthorsChristian J P A Hoebe, Angelique P A Vermeiren, Nicole H T M Dukers-Muijrers
JournalVaccine (Vaccine) Vol. 30 Issue 48 Pg. 6734-7 (Nov 6 2012) ISSN: 1873-2518 [Electronic] Netherlands
PMID22981848 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Engerix-B
  • Fendrix
  • HB-VAX
  • Hepatitis B Antibodies
  • Hepatitis B Vaccines
Topics
  • Adult
  • Cohort Studies
  • Female
  • Hepatitis B (prevention & control)
  • Hepatitis B Antibodies (blood)
  • Hepatitis B Vaccines (administration & dosage, immunology)
  • Humans
  • Immunization, Secondary (methods)
  • Male
  • Middle Aged
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: